Javascript is not enabled.

Javascript must be enabled to use this site. Please enable Javascript in your browser and try again.

FDA Questions the Effectiveness of Avastin-AARP Skip to content

Get the vision care news and information you need in the AARP Eye Center.


Avastin, The FDA and a Question of Effectiveness (Not Hope)

Medicare will continue paying for Avastin’s use as a treatment  for breast cancer, a spokesman said Thursday. This comes after an FDA panel voted Wednesday to revoke the drug’s approval for such treatment. Read

See also: Navigating breast cancer treatments

Join the Discussion

0 | Add Yours

Please leave your comment below.

You must be logged in to leave a comment.